Ignite Creation Date:
2025-12-25 @ 3:26 AM
Ignite Modification Date:
2026-05-18 @ 10:06 PM
Study NCT ID:
NCT01069705
Status:
COMPLETED
Last Update Posted:
2021-06-02
First Post:
2010-02-15
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Second Open Label Extension to Bridging Study CTBM100C2303
Sponsor:
Novartis Pharmaceuticals
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
CTBM100C2303E2
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None